Schering-Plough
SGP
#545
Rank
HK$361.32 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : HK$63.95 Billion

According to Schering-Plough's latest financial reports the company's total debt is HK$63.95 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31HK$63.18 B
2006-12-31HK$20.65 B-27.54%
2005-12-31HK$28.50 B-7.38%
2004-12-31HK$30.78 B15.68%
2003-12-31HK$26.60 B-20.89%
2002-12-31HK$33.63 B127.03%
2001-12-31HK$14.81 B-27.77%
2000-12-31HK$20.51 B
1998-12-31HK$15.89 B-16.44%
1997-12-31HK$19.02 B121.37%
1996-12-31HK$8.59 B